| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbdc68ca0aa38fef2d059853ef2b31e6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 |
| filingDate |
1996-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e07dfccc81bb465b4252e16bc7fdfc2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d313e3225dddacf5ccff45b89e61adf |
| publicationDate |
1998-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5763490-A |
| titleOfInvention |
Treating prostate cancer with tartrate ions |
| abstract |
A method is disclosed for treating prostate cancer in males by administration of tartrate ions from a tartrate derivative. The tartrate ions in the bloodstream bind to and inhibit prostatic acid phosphatase. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009285755-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8168159-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7514067-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004112773-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003021791-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9186425-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8603437-B2 |
| priorityDate |
1994-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |